American Oncology Network Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	42	204	419	406
Market Cap Growth	-	-51.17%	3.03%	-
Enterprise Value	104	266	507	436
PE Ratio	-36.90	-36.90	-	-
PS Ratio	0.03	0.16	0.36	0.43
PB Ratio	-1.26	-1.26	6.75	6.83
P/FCF Ratio	-6.89	-6.89	-35.21	-11.96
P/OCF Ratio	-11.29	-11.29	-61.73	-15.43
EV/Sales Ratio	0.08	0.21	0.44	0.46
EV/EBITDA Ratio	-6.66	-6.66	21.95	55.52
EV/EBIT Ratio	-4.70	-4.70	84.40	245.76
EV/FCF Ratio	-8.96	-8.96	-42.62	-12.83
Debt / Equity Ratio	-0.79	-0.79	2.04	1.07
Debt / EBITDA Ratio	-3.18	-3.18	5.49	8.11
Debt / FCF Ratio	-4.28	-4.28	-10.65	-1.87
Quick Ratio	1.35	1.35	1.44	1.43
Current Ratio	1.64	1.64	1.72	1.75
Asset Turnover	3.65	3.65	3.45	3.01
Interest Coverage	-8.83	-8.83	1.76	1.25
Return on Equity (ROE)	11.10%	11.10%	0.00%	0.00%
Return on Assets (ROA)	-1.60%	-1.60%	0.00%	0.00%
Return on Capital (ROIC)	142.10%	142.10%	2.95%	-0.22%
Earnings Yield	-13.05%	-2.71%	-	-
FCF Yield	-69.91%	-14.52%	-2.84%	-8.36%
Buyback Yield / Dilution	83.96%	13.46%	-	-
Total Shareholder Return	83.96%	13.46%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).